Organic compounds -- part of the class 532-570 series – Organic compounds – Sulfonate esters
Reexamination Certificate
2005-03-21
2011-10-18
Kumar, Shailendra (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Sulfonate esters
C546S233000, C548S568000, C514S033000, C514S428000, C514S517000
Reexamination Certificate
active
08039656
ABSTRACT:
4-(trifluoromethanesulfonyloxyphenyl)propionic acid derivatives and pharmaceutical composition containing such compounds are useful in inhibiting the chemotactic activation of neutrophils (PMN leukocytes) induced by the interaction of Interleukin-8 (IL-8) with CXCR1 and CXCR2 membrane receptors. The compounds are used for the prevention and treatment of pathologies deriving from said activation. Notably, these metabolites are devoid of cyclo-oxygenase inhibition activity and are particularly useful in the treatment of neutrophil-dependent pathologies such as psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), bullous pemphigoid, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and in the prevention and treatment of damages caused by ischemia and reperfusion.
REFERENCES:
patent: WO 00/24710 (2000-05-01), None
patent: WO 01/58852 (2001-08-01), None
patent: WO 02/068377 (2002-09-01), None
patent: WO 03/043625 (2003-05-01), None
Allegretti Marcello
Bertini Riccardo
Cesta Maria Candida
Colotta Francesco
Mosca Marco
Birch & Stewart Kolasch & Birch, LLP
Kumar Shailendra
LandOfFree
2-phenylpropionic acid derivatives and pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-phenylpropionic acid derivatives and pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-phenylpropionic acid derivatives and pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4252740